Is Yang Xinfang a national patent medicine at present?

Yes As of August 19, 2022, Yang Xinfang is a new chemical monomer drug with a patent application, which is a national patent drug. Yangxin recipe consists of Radix Astragali, Poria, Poria, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Glycyrrhizae Preparata, etc. It has the effects of invigorating qi and nourishing blood (supplementing qi and blood in the body), calming the heart and calming the nerves, and can be used for treating heart-blood deficiency, with symptoms such as uneasiness, palpitation and palpitation.